Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway - PubMed (original) (raw)

. 2001 Dec 28;276(52):48997-9002.

doi: 10.1074/jbc.M107829200. Epub 2001 Oct 3.

Affiliations

• PMID: 11585835
• DOI: 10.1074/jbc.M107829200

Free article

Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway

M T Lin et al. J Biol Chem. 2001.

Free article

Abstract

Cyclooxygenase 2 (COX-2) has been reported to be commonly expressed in advanced stages of human lung adenocarcinoma. In this study, the COX-2 constitutive expression vector was transfected into a human lung adenocarcinoma cell line CL1.0 and several clones were obtained which stably expressed COX-2. These COX-2-overexpressed clones demonstrated remarkable resistance to apoptosis induced by Ultraviolet B (UVB) irradiation, vinblastine B (VBL) cell lymphoma-2 (Bcl-2), or other anti-cancer drugs. To understand how COX-2 prevents apoptosis, the investigators examined the expression level of Bcl-2 family members. Mcl-1, but not other Bcl-2 members, was significantly up-regulated by COX-2 transfection or prostaglandin E(2) (PGE(2)) treatment. Treatment of COX-2-overexpressed cells (cox-2/cl.4) with two specific COX-2 inhibitors, NS-398 and celecoxib, caused an effective reduction of the increased level of Mcl-1. These data suggest that the expression level of Mcl-1 is tightly regulated by COX-2. Moreover, transfection of cox-2/cl.4 cells with antisense Mcl-1 enhanced apoptosis induced by UVB irradiation, revealing that Mcl-1 plays a crucial role in cell survival activity mediated by COX-2. Furthermore, COX-2 transfection or PGE(2) treatment evidently activated the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Inhibition of the PI3K pathway by LY294002 or wortmannin effectively attenuated the increased level of Mcl-1 induced by COX-2 or PGE(2). Blocking the PI3K activity with a dominant-negative vector, DN-p85, also greatly diminished the level of Mcl-1 and enhanced UVB-elicited cell death in cells transfected by COX-2. In a similar way, LY294002 inhibited cell survival and Mcl-1 level in PGE(2)-treated CL1.0 cells. These findings suggest that COX-2 promotes cell survival by up-regulating the level of Mcl-1 by activating the PI3K/Akt-dependent pathway.

PubMed Disclaimer

Similar articles

• The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
  Jee SH, Chiu HC, Tsai TF, Tsai WL, Liao YH, Chu CY, Kuo ML. Jee SH, et al. J Invest Dermatol. 2002 Nov;119(5):1121-7. doi: 10.1046/j.1523-1747.2002.19503.x. J Invest Dermatol. 2002. PMID: 12445202
• Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
  St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E. St-Germain ME, et al. Int J Oncol. 2004 May;24(5):1311-24. Int J Oncol. 2004. PMID: 15067356
• Physiological Functions of Mcl-1: Insights From Genetic Mouse Models.
  Chin HS, Fu NY. Chin HS, et al. Front Cell Dev Biol. 2021 Jul 16;9:704547. doi: 10.3389/fcell.2021.704547. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34336857 Free PMC article. Review.
• Prevention of ovarian cancer: intraepithelial neoplasia.
  Brewer MA, Johnson K, Follen M, Gershenson D, Bast R Jr. Brewer MA, et al. Clin Cancer Res. 2003 Jan;9(1):20-30. Clin Cancer Res. 2003. PMID: 12538447 Review.

Cited by

• Development and Clinical Validation of a Novel 5 Gene Signature Based on Fatty Acid Metabolism-Related Genes in Oral Squamous Cell Carcinoma.
  Fan Y, Wang J, Wang Y, Li Y, Wang S, Weng Y, Yang Q, Chen C, Lin L, Qiu Y, Wang J, Chen F, He B, Liu F. Fan Y, et al. Oxid Med Cell Longev. 2022 Nov 28;2022:3285393. doi: 10.1155/2022/3285393. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36478991 Free PMC article.
• Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer.
  Hermawan A, Putri H, Hanif N, Ikawati M. Hermawan A, et al. Evid Based Complement Alternat Med. 2021 Jul 13;2021:2234554. doi: 10.1155/2021/2234554. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34335799 Free PMC article.
• Novel mutations in BRCA2 intron 11 and overexpression of COX-2 and BIRC3 mediate cellular resistance to PARP inhibitors.
  Chen HD, Guo N, Song SS, Chen CH, Miao ZH, He JX. Chen HD, et al. Am J Cancer Res. 2020 Sep 1;10(9):2813-2831. eCollection 2020. Am J Cancer Res. 2020. PMID: 33042619 Free PMC article.
• PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis.
  Arnett E, Weaver AM, Woodyard KC, Montoya MJ, Li M, Hoang KV, Hayhurst A, Azad AK, Schlesinger LS. Arnett E, et al. PLoS Pathog. 2018 Jun 21;14(6):e1007100. doi: 10.1371/journal.ppat.1007100. eCollection 2018 Jun. PLoS Pathog. 2018. PMID: 29928066 Free PMC article.
• Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.
  Torres-Collado AX, Jazirehi AR. Torres-Collado AX, et al. Cancers (Basel). 2018 Jun 14;10(6):200. doi: 10.3390/cancers10060200. Cancers (Basel). 2018. PMID: 29904021 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal